Centene Corp Reaffirms 2026 EPS Guidance at DB Healthcare Summit

What Happened Centene Corporation filed a Form 8‑K on Sept. 16, 2026 disclosing that company management will participate in the Deutsche Bank 2026 Healthcare Summit on Wednesday, Sept. 16, 2026 at 9:00 a.m. EDT and will hold investor discussions through the week of Sept. 21. Management will discuss the company's business and financial results and reaffirmed its full‑year 2026 guidance: GAAP diluted EPS greater than $3.11 and adjusted diluted EPS greater than $4.80. A live audio webcast of the presentation was made available and a replay will be posted on Centene’s investor website.

Key Details

• Event: Deutsche Bank 2026 Healthcare Summit presentation on Sept. 16, 2026 at 9:00 a.m. EDT; investor discussions continue through week of Sept. 21.
• Guidance reaffirmed: full‑year 2026 GAAP diluted EPS > $3.11; adjusted diluted EPS > $4.80.
• Webcast: simultaneous live audio webcast provided; replay available via Centene’s website (Investors section).
• Non‑GAAP measures: company provided non‑GAAP metrics (excluding items such as amortization of acquired intangible assets and acquisition/divestiture related expenses) and referenced the July 28, 2026 press release (Exhibit 99.1) for reconciliation to GAAP.

Why It Matters For investors, the 8‑K confirms Centene’s continued public guidance for 2026 EPS levels and signals management will be actively communicating near‑term with investors at the conference. The filing also reiterates Centene’s use of adjusted (non‑GAAP) measures and points investors to the prior press release for the reconciliation to GAAP, which is important when comparing reported and adjusted results.